Association Between Dinutuximab Beta Exposure and Post‐End‐of‐Treatment Survival in Neuroblastoma: A Weighted Patient‐Level Analysis of Three Clinical Studies

Przemysław Holko, Holger N. Lode, Alberto Garaventa, Carla Manzitti, Roberto Luksch, Dominique Valteau‐Couanet, Marion Gambart, John Anderson, Juliet Gray, Adela Canete, Lucas Moreno, Aleksandra Wieczorek, Cormac Owens, Shifra Ash, Isaac Yaniv, Genevieve Laureys, Hans Loibner, Katarzyna Śladowska, Ruth Ladenstein, Paweł Kawalec

Open source

DOI: 10.1002/1545-5017.70502
Published: 2026-07-23
Container: Pediatric Blood & Cancer
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/1545-5017.70502,
  title = {Association Between Dinutuximab Beta Exposure and Post‐End‐of‐Treatment Survival in Neuroblastoma: A Weighted Patient‐Level Analysis of Three Clinical Studies},
  author = {Przemysław Holko and Holger N. Lode and Alberto Garaventa and Carla Manzitti and Roberto Luksch and Dominique Valteau‐Couanet and Marion Gambart and John Anderson and Juliet Gray and Adela Canete and Lucas Moreno and Aleksandra Wieczorek and Cormac Owens and Shifra Ash and Isaac Yaniv and Genevieve Laureys and Hans Loibner and Katarzyna Śladowska and Ruth Ladenstein and Paweł Kawalec},
  year = {2026},
  journal = {Pediatric Blood \&amp; Cancer},
  doi = {10.1002/1545-5017.70502},
  url = {https://doi.org/10.1002/1545-5017.70502}
}

RIS

TY  - JOUR
TI  - Association Between Dinutuximab Beta Exposure and Post‐End‐of‐Treatment Survival in Neuroblastoma: A Weighted Patient‐Level Analysis of Three Clinical Studies
AU  - Przemysław Holko
AU  - Holger N. Lode
AU  - Alberto Garaventa
AU  - Carla Manzitti
AU  - Roberto Luksch
AU  - Dominique Valteau‐Couanet
AU  - Marion Gambart
AU  - John Anderson
AU  - Juliet Gray
AU  - Adela Canete
AU  - Lucas Moreno
AU  - Aleksandra Wieczorek
AU  - Cormac Owens
AU  - Shifra Ash
AU  - Isaac Yaniv
AU  - Genevieve Laureys
AU  - Hans Loibner
AU  - Katarzyna Śladowska
AU  - Ruth Ladenstein
AU  - Paweł Kawalec
PY  - 2026
JO  - Pediatric Blood &amp; Cancer
DO  - 10.1002/1545-5017.70502
UR  - https://doi.org/10.1002/1545-5017.70502
ER  -

APA

Holko, P., Lode, H. N., Garaventa, A., Manzitti, C., Luksch, R., Valteau‐Couanet, D., Gambart, M., Anderson, J., Gray, J., Canete, A., Moreno, L., Wieczorek, A., Owens, C., Ash, S., Yaniv, I., Laureys, G., Loibner, H., Śladowska, K., Ladenstein, R., & Kawalec, P. (2026). Association Between Dinutuximab Beta Exposure and Post‐End‐of‐Treatment Survival in Neuroblastoma: A Weighted Patient‐Level Analysis of Three Clinical Studies. Pediatric Blood & Cancer. https://doi.org/10.1002/1545-5017.70502

Source records

crossref · retrieved 2026-09-25T08:08:57.682Z